Geode Capital Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-18,677
| Closed | -$13.6K | – | 4734 |
|
|
2023
Q4 | $13.6K | Hold |
18,677
| – | – | ﹤0.01% | 4563 |
|
|
2023
Q3 | $22.2K | Buy |
18,677
+7,508
| +67% | +$9.34K | ﹤0.01% | 4606 |
|
|
2023
Q2 | $15.2K | Hold |
11,169
| – | – | ﹤0.01% | 4688 |
|
|
2023
Q1 | $11.8K | Hold |
11,169
| – | – | ﹤0.01% | 4759 |
|
|
2022
Q4 | $26K | Hold |
11,169
| – | – | ﹤0.01% | 4731 |
|
|
2022
Q3 | $47K | Buy |
11,169
+123
| +1% | +$673 | ﹤0.01% | 4781 |
|
|
2022
Q2 | $44K | Buy |
11,046
+1
| +0% | +$5 | ﹤0.01% | 4805 |
|
|
2022
Q1 | $95K | Hold |
11,045
| – | – | ﹤0.01% | 4680 |
|
|
2021
Q4 | $126K | Hold |
11,045
| – | – | ﹤0.01% | 4652 |
|
|
2021
Q3 | $192K | Hold |
11,045
| – | – | ﹤0.01% | 4467 |
|
|
2021
Q2 | $205K | Buy |
11,045
+3,577
| +48% | +$68.1K | ﹤0.01% | 4337 |
|
|
2021
Q1 | $185K | Buy |
7,468
+5,705
| +324% | +$171K | ﹤0.01% | 4137 |
|
|
2020
Q4 | $35K | Buy |
+1,763
| New | +$34.5K | ﹤0.01% | 4215 |
|
|
2020
Q1 | – | Sell |
-13
| Closed | -$2K | – | 4283 |
|
|
2019
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 4207 |
|
|
2019
Q3 | $5K | Hold |
13
| – | – | ﹤0.01% | 4192 |
|
|
2019
Q2 | $7K | Hold |
13
| – | – | ﹤0.01% | 4198 |
|
|
2019
Q1 | $15K | Hold |
13
| – | – | ﹤0.01% | 4111 |
|
|
2018
Q4 | $15K | Hold |
13
| – | – | ﹤0.01% | 4116 |
|
|
2018
Q3 | $20K | Hold |
13
| – | – | ﹤0.01% | 4095 |
|
|
2018
Q2 | $17K | Buy |
13
+4
| +44% | +$21.9K | ﹤0.01% | 4043 |
|
|
2018
Q1 | $93K | Hold |
9
| – | – | ﹤0.01% | 3861 |
|
|
2017
Q4 | $133K | Sell |
9
-1
| -10% | -$23.1K | ﹤0.01% | 3762 |
|
|
2017
Q3 | $265K | Hold |
10
| – | – | ﹤0.01% | 3577 |
|
|
2017
Q2 | $485K | Sell |
10
-3
| -23% | -$164K | ﹤0.01% | 3364 |
|
|
2017
Q1 | $956K | Buy |
13
+1
| +8% | +$80.8K | ﹤0.01% | 3040 |
|
|
2016
Q4 | $960K | Hold |
12
| – | – | ﹤0.01% | 3009 |
|
|
2016
Q3 | $1.48M | Buy |
12
+1
| +9% | +$125K | ﹤0.01% | 2731 |
|
|
2016
Q2 | $1.16M | Hold |
11
| – | – | ﹤0.01% | 2818 |
|
|
2016
Q1 | $1.39K | Buy |
11
+2
| +22% | +$215K | ﹤0.01% | 2697 |
|
|
2015
Q4 | $1.2M | Hold |
9
| – | – | ﹤0.01% | 2804 |
|
|
2015
Q3 | $1.43M | Buy |
+9
| New | +$2.1M | ﹤0.01% | 2657 |
|
Other funds holding NVIV
Geode Capital Management's NVIV Position: Q1 2024 in Review
Geode Capital Management sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q1 2024, closing a stake of 18,677 shares — an estimated $13.6K sold.
Geode Capital Management first reported a position in NVIV in Q3 2015 and held it in 31 quarters. The position peaked at $1.48M in Q3 2016. 4 funds tracked by Wall St. Rank hold NVIV as of Q1 2024.
- Geode Capital Management reported no remaining InVivo Therapeutics Holdings Corp position as of Q1 2024 after selling out during the quarter.
- Geode Capital Management sold 18,677 InVivo Therapeutics Holdings Corp shares in Q1 2024, an estimated $13.6K.
- Geode Capital Management first reported a position in InVivo Therapeutics Holdings Corp in Q3 2015 and held it in 31 quarters.
- Geode Capital Management's InVivo Therapeutics Holdings Corp position peaked at $1.48M in Q3 2016.
- 4 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2024.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.